Published in AIDS Behav on June 08, 2016
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA (2006) 17.93
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc (2004) 6.64
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38
Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol (2004) 4.90
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol (2002) 3.10
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis (2014) 3.09
Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Res Hum Retroviruses (2008) 1.84
Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev (2009) 1.73
Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J Neurovirol (2007) 1.73
Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol (1993) 1.67
Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol (2008) 1.64
Aging, neurocognition, and medication adherence in HIV infection. Am J Geriatr Psychiatry (2009) 1.64
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol (2012) 1.60
Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev (2009) 1.54
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc (2011) 1.53
Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol (2007) 1.35
Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol (2006) 1.33
Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav (2011) 1.33
Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev (2009) 1.31
HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol (2010) 1.31
Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J Neurovirol (2007) 1.30
Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc (2010) 1.20
HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia. AIDS Behav (2011) 1.12
Neuropsychiatric correlates of memory-metamemory dissociations in HIV-infection. J Clin Exp Neuropsychol (1999) 1.09
Better quality of life with neuropsychological improvement on HAART. Health Qual Life Outcomes (2006) 1.08
Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia, Africa. J Nerv Ment Dis (2012) 1.06
Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s). HIV Clin Trials (2010) 1.03
HIV-associated cognitive impairment in sub-Saharan Africa--the potential effect of clade diversity. Nat Clin Pract Neurol (2007) 1.03
The impact of neuropsychological performance on everyday functioning between older and younger adults with and without HIV. J Assoc Nurses AIDS Care (2012) 1.02
Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample. J Neurol Sci (2008) 1.00
A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. J Neurovirol (2011) 0.96
Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease. Health Qual Life Outcomes (2003) 0.96
Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis. Int J Infect Dis (2013) 0.91
Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana. PLoS One (2011) 0.89
The relationship between plasma viral load and neuropsychological functioning in HIV-1 infection. Arch Clin Neuropsychol (2005) 0.86
Neuropsychological impairment and gender differences in HIV-1 infection. Psychiatry Clin Neurosci (2008) 0.83
Neurology and the Global HIV Epidemic. Semin Neurol (2014) 0.81
Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer. J Nurs Meas (2013) 0.80
Neuroimaging abnormalities and seizure recurrence in a prospective cohort study of zambians with human immunodeficiency virus and first seizure. Neurol Int (2014) 0.77